Ocuphire Pharma Inc

+0.03 (+1.49%)
Earnings Announcements

Ocuphire Pharma Reports Qtrly Net Loss Per Share Of $0.35

Published: 03/24/2022 12:10 GMT
Ocuphire Pharma Inc (OCUP) - Ocuphire Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2021 and Provides Corporate Update.
Believes Current Cash on Hand Will Be Sufficient to Fund Operations Into Q2 of 2023.
Qtrly Net Loss per Share Basic and Diluted $0.35.
Q4 Earnings per Share View $-0.29 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.35

More details on our Analysts Page.